GlassScriptPhysician profile
Hilary Gaudreau
NPI 1194865956
$1,552.18
in general payments reported to CMS, 2019-2025
21 companies · $31.73 in 2025
The $31.73 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.27 · 2020: $108 · 2021: $308 · 2022: $643 · 2023: $372 · 2025: $31.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $553.88 | 2020-2023 | |
| Medtronic, INC. | $136.39 | 2023 | V-Loc 180 |
| Aspira Women'S Health INC | $133.88 | 2022 | |
| Pfizer INC. | $105.42 | 2020-2023 | |
| Myovant Sciences INC. | $98.59 | 2021-2022 | |
| Agile Therapeutics, INC. | $97.18 | 2021-2022 | |
| Avion Pharmaceuticals | $67.33 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $56.57 | 2021-2023 | |
| Smith+Nephew, INC. | $51.31 | 2023-2025 | Renasys Touch, Pico, Pico 7 |
| Hologic Sales and Service, LLC | $43.38 | 2022-2023 | Acessa Provu System, Novasure, Coolseal Generator |
| Astellas Pharma US INC | $37.64 | 2019-2020 | |
| Exeltis, USA INC. | $32.05 | 2022 | |
| Allergan, INC. | $22.53 | 2019 | |
| Evofem Biosciences, INC. | $17.16 | 2021 | |
| Channel Medsystems, INC. | $16.46 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.02 | 2022 | |
| Kci USA, INC. | $14.61 | 2022 | |
| Duchesnay USA Incorporated | $14.14 | 2019 | |
| Therapeuticsmd, INC. | $13.34 | 2019 | |
| Lupin INC. | $13.03 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilary Gaudreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.